These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25500324)

  • 1. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunity, satisfaction, and regret: Trying long-acting reversible contraception in a unique scientific circumstance.
    Burke HM; Packer CA; Spector HL; Hubacher D
    Women Health; 2019 Mar; 59(3):266-280. PubMed ID: 29920171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
    Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
    Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
    Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Goyal V; Canfield C; Aiken ARA; Dermish A; Potter JE
    Obstet Gynecol; 2017 Apr; 129(4):655-662. PubMed ID: 28277358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four-month continuation of reversible contraception.
    O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
    Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting reversible contraception.
    Peck SA
    Nurs Womens Health; 2013 Oct; 17(5):431-5. PubMed ID: 24138662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
    Sapkota S; Rajbhandary R; Lohani S
    Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
    Broecker J; Jurich J; Fuchs R
    Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
    Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
    J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Condom use in adolescents and young women following initiation of long- or short-acting contraceptive methods.
    Bastow B; Sheeder J; Guiahi M; Teal S
    Contraception; 2018 Jan; 97(1):70-75. PubMed ID: 29031814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.